Press Releases

September 16, 2019

ProMIS Neurosciences Executive Chairman Eugene Williams to Speak on Panel at Fall Investor Summit

September 3, 2019

ProMIS Neurosciences to Present at HC Wainwright Investor Conference 

August 27, 2019

ProMIS Neurosciences Appoints Internationally Recognized Researcher in Alzheimer’s Disease in Down Syndrome Dr. Andre Strydom to its Scientific Advisory Board 

Press Archives

In the News

June 13, 2019

The Big Biz Show – Interview with Dr. Elliot Goldstein

June 11, 2019

European Biopharmaceutical Review July 2019

May 28, 2019

UCSF – Alzheimer’s Disease is a ‘Double-Prion Disorder,’ Study Shows

News Archives

Presentations

September 10, 2019

Executive Chairman Gene William’s Presentation at the HC Wainwright Investor Conference

August 12, 2019

CSO Neil Cashman’s overview of ProMIS’ unique capability to selectively target toxic, misfolded proteins that are root causes of neurodegenerative diseases

August 6, 2019

Dr. James Kupiec’s update from AAIC 2019: Demonstrating Early Proof-of-Concept with Biomarkers and Focused Patient Populations

Presentations Archives

Videos

August 6, 2019

Dr. James Kupiec’s update from AAIC 2019: Demonstrating Early Proof-of-Concept with Biomarkers and Focused Patient Populations

July 18, 2019

ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019 

November 20, 2018

Narrated year to date overview Nov 2018 – video

Video Archives